Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models

Frontiers in Neuroendocrinology

Volumn 35, Issue 4, 2014, Pages 494-511

  Roland, Alison V ^a   Moenter, Suzanne M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Androgens; Gonadotropin releasing hormone neurons; Polycystic ovary syndrome; Prenatal androgenization

Indexed keywords

ESTRADIOL; ESTROGEN; GONADORELIN; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE;

ANDROGEN METABOLISM; ANDROGENESIS; CELL FUNCTION; DISEASE MODEL; FEEDBACK SYSTEM; GONADOTROPIN RELEASING HORMONE NEURON; METABOLIC REGULATION; MOUSE MODEL; NERVE CELL; NEUROENDOCRINE DISEASE; NONHUMAN; OVARY DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRENATAL PERIOD; RAT MODEL; REVIEW; RHESUS MONKEY; SHEEP; STEROID THERAPY; ANIMAL; ANIMAL MODEL; FEMALE; HUMAN; METABOLISM; NEUROSECRETION;

ANIMALS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MODELS, ANIMAL; NEUROSECRETORY SYSTEMS; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 84908161108     PISSN: 00913022     EISSN: 10956808     Source Type: Journal    
DOI: 10.1016/j.yfrne.2014.04.002     Document Type: Review

References (162)

1. Abbott D.H., Dumesic D.A., Eisner J.R., Colman R.J., Kemnitz J.W. Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol. Metab. (TEM) 1998, 9:62-67.
2. Abbott D.H., Dumesic D.A., Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 2002, 174:1-5.
3. Abbott D.H., Barnett D.K., Bruns C.M., Dumesic D.A. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?. Hum. Reprod. Update 2005, 11:357-374. 10.1093/humupd/dmi013.
4. Abbott D.H., Barnett D.K., Levine J.E., Padmanabhan V., Dumesic D.A., Jacoris S., Tarantal A.F. Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biol. Reprod. 2008, 79:154-163. 10.1095/biolreprod.108.067702.
5. Abbott D.H., Tarantal A.F., Dumesic D.A. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am. J. Primatol. 2009, 71:776-784. 10.1002/ajp.20679.
6. Abbott D.H., Bruns C.R., Barnett D.K., Dunaif A., Goodfriend T.L., Dumesic D.A., Tarantal A.F. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E741-E751. 10.1152/ajpendo.00058.2010.
7. Abe H., Terasawa E. Firing pattern and rapid modulation of activity by estrogen in primate luteinizing hormone releasing hormone-1 neurons. Endocrinology 2005, 146:4312-4320. 10.1210/en.2005-0435.
8. Abi Salloum B., Herkimer C., Lee J.S., Veiga-Lopez A., Padmanabhan V. Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. Endocrinology 2012, 153:2813-2822. 10.1210/en.2011-2074.
9. Anderson H., Fogel N., Grebe S.K., Singh R.J., Taylor R.L., Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J. Clin. Endocrinol. Metab. 2010, 95:2180-2186. 10.1210/jc.2009-2651.
10. Barry J.A., Kay A.R., Navaratnarajah R., Iqbal S., Bamfo J.E.A.K., David A.L., Hines M., Hardiman P.J. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol. 2010, 30:444-446. 10.3109/01443615.2010.485254.
11. Barnes R.B., Rosenfield R.L., Ehrmann D.A., Cara J.F., Cuttler L., Levitsky L.L., Rosenthal I.M. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab. 1994, 79:1328-1333. 10.1210/jcem.79.5.7962325.
12. Beller, J., Abshire, M., Burt Solorzano, C., Collins, J., McCartney, C., Marshall, J., 2012. Developmental Resistance to Progesterone Negative Feedback in Hyperandrogenemic Adolescent Girls: Evidence for the Evolution of GnRH Pulse Patterns through Puberty. 94th Meeting of the Endocrine Society. Abstract SUN-35.
13. Birch R.A., Padmanabhan V., Foster D.L., Unsworth W.P., Robinson J.E. Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology 2003, 144:1426-1434.
14. Blank S.K., McCartney C.R., Chhabra S., Helm K.D., Eagleson C.A., Chang R.J., Marshall J.C. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls - implications for regulation of pubertal maturation. J. Clin. Endocrinol. Metab. 2009, 94:2360-2366. 10.1210/jc.2008-2606.
15. Brill D.S., Moenter S.M. Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice. Biol. Reprod. 2009, 81:1093-1098. 10.1095/biolreprod.109.079301.
16. Brothers K.J., Wu S., DiVall S.A., Messmer M.R., Kahn C.R., Miller R.S., Radovick S., Wondisford F.E., Wolfe A. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab. 2010, 12:295-305. 10.1016/j.cmet.2010.06.010.
17. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
18. Bucholtz D.C., Vidwans N.M., Herbosa C.G., Schillo K.K., Foster D.L. Metabolic interfaces between growth and reproduction. V. Pulsatile luteinizing hormone secretion is dependent on glucose availability. Endocrinology 1996, 137:601-607.
19. Chappell P.E., Levine J.E. Stimulation of gonadotropin-releasing hormone surges by estrogen. I. Role of hypothalamic progesterone receptors. Endocrinology 2000, 141:1477-1485.
20. Chappell P.E., Schneider J.S., Kim P., Xu M., Lydon J.P., O'Malley B.W., Levine J.E. Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice. Endocrinology 1999, 140:3653-3658.
21. Chen P., Moenter S.M. GABAergic transmission to gonadotropin-releasing hormone (GnRH) neurons is regulated by GnRH in a concentration-dependent manner engaging multiple signaling pathways. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29:9809-9818. 10.1523/JNEUROSCI.2509-09.2009.
22. Cheng G., Coolen L.M., Padmanabhan V., Goodman R.L., Lehman M.N. The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology 2010, 151:301-311. 10.1210/en.2009-0541.
23. Chhabra S., McCartney C.R., Yoo R.Y., Eagleson C.A., Chang R.J., Marshall J.C. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J. Clin. Endocrinol. Metab. 2005, 90:2810-2815. 10.1210/jc.2004-2359.
24. Christian C.A., Mobley J.L., Moenter S.M. Diurnal and estradiol-dependent changes in gonadotropin-releasing hormone neuron firing activity. Proc. Natl. Acad. Sci. USA 2005, 102:15682-15687. 10.1073/pnas.0504270102.
25. Coviello A.D., Legro R.S., Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 2006, 91:492-497. 10.1210/jc.2005-1666.
26. Cui L., Zhao H., Zhang B., Qu Z., Liu J., Liang X., Zhao X., Zhao J., Sun Y., Wang P., Li T., Shi Y., Chen Z.-J. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum. Reprod. Oxf. Engl. 2013, 28:538-544. 10.1093/humrep/des424.
27. De Zegher F., Ibáñez L. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil. Steril. 2006, 86(Suppl. 1):S4-S5. 10.1016/j.fertnstert.2006.03.013.
28. DeFazio R.A., Heger S., Ojeda S.R., Moenter S.M. Activation of A-type gamma-aminobutyric acid receptors excites gonadotropin-releasing hormone neurons. Mol. Endocrinol. 2002, 16:2872-2891.
29. Demissie M., Lazic M., Foecking E.M., Aird F., Dunaif A., Levine J.E. Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E262-E268. 10.1152/ajpendo.90208.2008.
30. Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 2012, 33:981-1030. 10.1210/er.2011-1034.
31. Divall S.A., Williams T.R., Carver S.E., Koch L., Brüning J.C., Kahn C.R., Wondisford F., Radovick S., Wolfe A. Divergent roles of growth factors in the GnRH regulation of puberty in mice. J. Clin. Invest. 2010, 120:2900-2909. 10.1172/JCI41069.
32. Dumesic D.A., Lobo R.A. Cancer risk and PCOS. Steroids 2013, 78:782-785. 10.1016/j.steroids.2013.04.004.
33. Dumesic D.A., Schramm R.D., Peterson E., Paprocki A.M., Zhou R., Abbott D.H. Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J. Clin. Endocrinol. Metab. 2002, 87:1111-1119.
34. Dumesic D.A., Abbott D.H., Eisner J.R., Goy R.W. Prenatal exposure of female rhesus monkeys to testosterone propionate increases serum luteinizing hormone levels in adulthood. Fertil. Steril. 1997, 67:155-163.
35. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 1997, 18:774-800.
36. Eagleson C.A., Gingrich M.B., Pastor C.L., Arora T.K., Burt C.M., Evans W.S., Marshall J.C. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 2000, 85:4047-4052.
37. Eisner J.R., Dumesic D.A., Kemnitz J.W., Abbott D.H. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J. Clin. Endocrinol. Metab. 2000, 85:1206-1210.
38. Eisner J.R., Barnett M.A., Dumesic D.A., Abbott D.H. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil. Steril. 2002, 77:167-172.
39. Eisner J.R., Dumesic D.A., Kemnitz J.W., Colman R.J., Abbott D.H. Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obes. Res. 2003, 11:279-286. 10.1038/oby.2003.42.
40. Fauser B.C.J.M., Tarlatzis B.C., Rebar R.W., Legro R.S., Balen A.H., Lobo R., Carmina E., Chang J., Yildiz B.O., Laven J.S.E., Boivin J., Petraglia F., Wijeyeratne C.N., Norman R.J., Dunaif A., Franks S., Wild R.A., Dumesic D., Barnhart K. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group. Fertil. Steril. 2012, 97(28-38):e25. 10.1016/j.fertnstert.2011.09.024.
41. Foecking E.M., Levine J.E. Effects of experimental hyperandrogenemia on the female rat reproductive axis: suppression of progesterone-receptor messenger RNA expression in the brain and blockade of luteinizing hormone surges. Gend. Med. 2005, 2:155-165.
42. Foecking E.M., Szabo M., Schwartz N.B., Levine J.E. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biol. Reprod. 2005, 72:1475-1483. 10.1095/biolreprod.105.039800.
43. Foecking E.M., McDevitt M.A., Acosta-Martínez M., Horton T.H., Levine J.E. Neuroendocrine consequences of androgen excess in female rodents. Horm. Behav. 2008, 53:673-692. 10.1016/j.yhbeh.2007.12.013.
44. Genazzani A.D., Battaglia C., Malavasi B., Strucchi C., Tortolani F., Gamba O. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil. Steril. 2004, 81:114-119.
45. Genazzani A.D., Strucchi C., Luisi M., Casarosa E., Lanzoni C., Baraldi E., Ricchieri F., Mehmeti H., Genazzani A.R. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 2006, 22:36-43. 10.1080/09513590500476164.
46. Gilling-Smith C., Willis D.S., Beard R.W., Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 1994, 79:1158-1165.
47. Glanowska K.M., Venton B.J., Moenter S.M. Fast scan cyclic voltammetry as a novel method for detection of real-time gonadotropin-releasing hormone release in mouse brain slices. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32:14664-14669. 10.1523/JNEUROSCI.1303-12.2012.
48. Goodarzi M.O., Jones M.R., Li X., Chua A.K., Garcia O.A., Chen Y.-D.I., Krauss R.M., Rotter J.I., Ankener W., Legro R.S., Azziz R., Strauss J.F., Dunaif A., Urbanek M. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J. Med. Genet. 2012, 49:90-95. 10.1136/jmedgenet-2011-100427.
49. Goodman R.L., Lehman M.N. Kisspeptin neurons from mice to men: similarities and differences. Endocrinology 2012, 153:5105-5118. 10.1210/en.2012-1550.
50. Goodman R.L., Coolen L.M., Anderson G.M., Hardy S.L., Valent M., Connors J.M., Fitzgerald M.E., Lehman M.N. Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep. Endocrinology 2004, 145:2959-2967. 10.1210/en.2003-1305.
51. Goy R.W., Resko J.A. Gonadal hormones and behavior of normal and pseudohermaphroditic nonhuman female primates. Recent Prog. Horm. Res. 1972, 28:707-733.
52. Gray L.E., Wilson V.S., Stoker T., Lambright C., Furr J., Noriega N., Howdeshell K., Ankley G.T., Guillette L. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int. J. Androl. 2006, 29:96-104. (discussion 105-108). 10.1111/j.1365-2605.2005.00636.x.
53. Grenman S., Rönnemaa T., Irjala K., Kaihola H.L., Grönroos M. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J. Clin. Endocrinol. Metab. 1986, 63:1257-1261.
54. Handa R.J., Gorski R.A. Alterations in the onset of ovulatory failure and gonadotropin secretion following steroid administration to lightly androgenized female rats. Biol. Reprod. 1985, 32:248-256.
55. He D., Funabashi T., Sano A., Uemura T., Minaguchi H., Kimura F. Effects of glucose and related substrates on the recovery of the electrical activity of gonadotropin-releasing hormone pulse generator which is decreased by insulin-induced hypoglycemia in the estrogen-primed ovariectomized rat. Brain Res. 1999, 820:71-76.
56. Herbison A.E., Moenter S.M. Depolarising and hyperpolarising actions of GABA(A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus. J. Neuroendocrinol. 2011, 23:557-569. 10.1111/j.1365-2826.2011.02145.x.
57. Herbosa C.G., Dahl G.E., Evans N.P., Pelt J., Wood R.I., Foster D.L. Sexual differentiation of the surge mode of gonadotropin secretion: prenatal androgens abolish the gonadotropin-releasing hormone surge in the sheep. J. Neuroendocrinol. 1996, 8:627-633.
58. Hogg K., McNeilly A.S., Duncan W.C. Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology 2011, 152:2048-2059. 10.1210/en.2010-1219.
59. Hogg K., Young J.M., Oliver E.M., Souza C.J., McNeilly A.S., Duncan W.C. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 2012, 153:450-461. 10.1210/en.2011-1607.
60. Huang W., Acosta-Martínez M., Horton T.H., Levine J.E. Fasting-induced suppression of LH secretion does not require activation of ATP-sensitive potassium channels. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1439-E1446. 10.1152/ajpendo.90615.2008.
61. Hughes C., Elgasim M., Layfield R., Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review. Hum. Reprod. Oxf. Engl. 2006, 21:2766-2775. 10.1093/humrep/del222.
62. Ibáñez L., Potau N., Carrascosa A. Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS). Trends Endocrinol. Metab. (TEM) 1998, 9:72-77.
63. Ibáñez L., Valls C., Potau N., Marcos M.V., de Zegher F. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clin. Endocrinol. (Oxf.) 2001, 55:667-672.
64. Ibáñez L., Ferrer A., Ong K., Amin R., Dunger D., de Zegher F. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J. Pediatr. 2004, 144:23-29. 10.1016/j.jpeds.2003.08.015.
65. Ibáñez L., López-Bermejo A., Díaz M., Marcos M.V., de Zegher F. Early metformin therapy (age 8-12years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J. Clin. Endocrinol. Metab. 2011, 96:E1262-1267. 10.1210/jc.2011-0555.
66. Jackson L.M., Timmer K.M., Foster D.L. Organizational actions of postnatal estradiol in female sheep treated prenatally with testosterone: programming of prepubertal neuroendocrine function and the onset of puberty. Endocrinology 2009, 150:2317-2324. 10.1210/en.2008-1307.
67. Jackson L.M., Mytinger A., Roberts E.K., Lee T.M., Foster D.L., Padmanabhan V., Jansen H.T. Developmental programming: postnatal steroids complete prenatal steroid actions to differentially organize the GnRH surge mechanism and reproductive behavior in female sheep. Endocrinology 2013, 154:1612-1623. 10.1210/en.2012-1613.
68. Jain A., Polotsky A.J., Rochester D., Berga S.L., Loucks T., Zeitlian G., Gibbs K., Polotsky H.N., Feng S., Isaac B., Santoro N. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J. Clin. Endocrinol. Metab. 2007, 92:2468-2473. 10.1210/jc.2006-2274.
69. Jansen H.T., Hershey J., Mytinger A., Foster D.L., Padmanabhan V. Developmental programming: reproductive endocrinopathies in the adult female sheep after prenatal testosterone treatment are reflected in altered ontogeny of GnRH afferents. Endocrinology 2011, 152:4288-4297. 10.1210/en.2011-0117.
70. Jeon Y.E., Lee K.E., Jung J.A., Yim S.Y., Kim H., Seo S.K., Cho S., Choi Y.S., Lee B.S. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol. Obstet. Invest. 2013, 75:268-274. 10.1159/000350217.
71. Karsch F.J., Dierschke D.J., Knobil E. Sexual differentiation of pituitary function: apparent difference between primates and rodents. Science 1973, 179:484-486.
72. Katsiki N., Georgiadou E., Hatzitolios A.I. The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Drugs 2009, 69:1417-1431. 10.2165/00003495-200969110-00002.
73. Kauffman A.S. Coming of age in the kisspeptin era: sex differences, development, and puberty. Mol. Cell. Endocrinol. 2010, 324:51-63. 10.1016/j.mce.2010.01.017.
74. Kenealy B.P., Terasawa E. Rapid direct action of estradiol in GnRH neurons: findings and implications. Front. Endocrinol. 2011, 2:106. 10.3389/fendo.2011.00106.
75. Kim S.J., Foster D.L., Wood R.I. Prenatal testosterone masculinizes synaptic input to gonadotropin-releasing hormone neurons in sheep. Biol. Reprod. 1999, 61:599-605.
76. King S.R., Manna P.R., Ishii T., Syapin P.J., Ginsberg S.D., Wilson K., Walsh L.P., Parker K.L., Stocco D.M., Smith R.G., Lamb D.J. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J. Neurosci. Off. J. Soc. Neurosci. 2002, 22:10613-10620.
77. Kjerulff L.E., Sanchez-Ramos L., Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am. J. Obstet. Gynecol. 2011, 204(558):e1-e6. 10.1016/j.ajog.2011.03.021.
78. Knobil E., Plant T.M., Wildt L., Belchetz P.E., Marshall G. Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone. Science 1980, 207:1371-1373.
79. Knudsen K.L., Blank S.K., Burt Solorzano C., Patrie J.T., Chang R.J., Caprio S., Marshall J.C., McCartney C.R. Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants. Obesity 2010, 18:2118-2124. 10.1038/oby.2010.58.
80. Kola B., Boscaro M., Rutter G.A., Grossman A.B., Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab. (TEM) 2006, 17:205-215. 10.1016/j.tem.2006.05.006.
81. Kosut S.S., Wood R.I., Herbosa-Encarnación C., Foster D.L. Prenatal androgens time neuroendocrine puberty in the sheep: effect of testosterone dose. Endocrinology 1997, 138:1072-1077.
82. Kubota Y., Hatada S., Kondo S., Karube F., Kawaguchi Y. Neocortical inhibitory terminals innervate dendritic spines targeted by thalamocortical afferents. J. Neurosci. Off. J. Soc. Neurosci. 2007, 27:1139-1150. 10.1523/JNEUROSCI.3846-06.2007.
83. Lehman M.N., Coolen L.M., Goodman R.L. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 2010, 151:3479-3489. 10.1210/en.2010-0022.
84. Levine, J.E., Terasawa, E., Hoffman, S.M., Dobbert, M.J.W., Foecking, E.M., Abbott, D.H., 2005. Luteinizing hormone (LH) hypersecretion and diminished LH responses to RU486 in a non human primate model for polycystic ovary syndrome (PCOS). Annu. Meet. Endocr. Soc. June 4, 2005, San Diego, CA.
85. Lim S.S., Davies M.J., Norman R.J., Moran L.J. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 2012, 18:618-637. 10.1093/humupd/dms030.
86. Longo S., Bollani L., Decembrino L., Di Comite A., Angelini M., Stronati M. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J. Matern.-Fetal Neonatal Med. Off. J. Eur. Assoc. Perinat. Med. Fed. Asia Ocean. Perinat. Soc. Int. Soc. Perinat. Obstet. 2013, 26:222-225. 10.3109/14767058.2012.715006.
87. Maliqueo M., Lara H.E., Sánchez F., Echiburú B., Crisosto N., Sir-Petermann T. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 166:151-155. 10.1016/j.ejogrb.2012.10.015.
88. Manikkam M., Crespi E.J., Doop D.D., Herkimer C., Lee J.S., Yu S., Brown M.B., Foster D.L., Padmanabhan V. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004, 145:790-798. 10.1210/en.2003-0478.
89. Manikkam M., Thompson R.C., Herkimer C., Welch K.B., Flak J., Karsch F.J., Padmanabhan V. Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol. Reprod. 2008, 78:648-660. 10.1095/biolreprod.107.063347.
90. Marshall J.C., Eagleson C.A. Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 1999, 28:295-324.
91. Masek K.S., Wood R.I., Foster D.L. Prenatal dihydrotestosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in sheep. Endocrinology 1999, 140:3459-3466.
92. McCartney C.R., Prendergast K.A., Chhabra S., Eagleson C.A., Yoo R., Chang R.J., Foster C.M., Marshall J.C. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J. Clin. Endocrinol. Metab. 2006, 91:1714-1722. 10.1210/jc.2005-1852.
93. McCartney C.R., Blank S.K., Prendergast K.A., Chhabra S., Eagleson C.A., Helm K.D., Yoo R., Chang R.J., Foster C.M., Caprio S., Marshall J.C. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J. Clin. Endocrinol. Metab. 2007, 92:430-436. 10.1210/jc.2006-2002.
94. McGee W.K., Bishop C.V., Bahar A., Pohl C.R., Chang R.J., Marshall J.C., Pau F.K., Stouffer R.L., Cameron J.L. Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome. Hum. Reprod. Oxf. Engl. 2012, 27:531-540. 10.1093/humrep/der393.
95. Melo A.S., Vieira C.S., Barbieri M.A., Rosa-E-Silva A.C.J.S., Silva A.A.M., Cardoso V.C., Reis R.M., Ferriani R.A., Silva-de-Sá M.F., Bettiol H. High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum. Reprod. Oxf. Engl. 2010, 25:2124-2131. 10.1093/humrep/deq162.
96. Moenter S.M., Chu Z. Rapid nongenomic effects of oestradiol on gonadotrophin-releasing hormone neurones. J. Neuroendocrinol. 2012, 24:117-121. 10.1111/j.1365-2826.2011.02135.x.
97. Moenter S.M., Caraty A., Locatelli A., Karsch F.J. Pattern of gonadotropin-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: existence of a preovulatory GnRH surge. Endocrinology 1991, 129:1175-1182. 10.1210/endo-129-3-1175.
98. Moore A.M., Prescott M., Campbell R.E. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology 2013, 154:796-806. 10.1210/en.2012-1954.
99. Morales A.J., Laughlin G.A., Bützow T., Maheshwari H., Baumann G., Yen S.S. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab. 1996, 81:2854-2864.
100. Morrison J.L., Duffield J.A., Muhlhausler B.S., Gentili S., McMillen I.C. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr. Nephrol. 2010, 25:669-677. 10.1007/s00467-009-1407-3.
101. Ohkura S., Ichimaru T., Itoh F., Matsuyama S., Okamura H. Further evidence for the role of glucose as a metabolic regulator of hypothalamic gonadotropin-releasing hormone pulse generator activity in goats. Endocrinology 2004, 145:3239-3246. 10.1210/en.2003-1516.
102. Ortega H.H., Salvetti N.R., Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction 2009, 137:865-877. 10.1530/REP-08-0491.
103. Padmanabhan V., Veiga-Lopez A. Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin. Reprod. Med. 2011, 29:173-186. 10.1055/s-0031-1275519.
104. Padmanabhan V., Veiga-Lopez A. Animal models of the polycystic ovary syndrome phenotype. Steroids 2013, 78:734-740. 10.1016/j.steroids.2013.05.004.
105. Pagán Y.L., Srouji S.S., Jimenez Y., Emerson A., Gill S., Hall J.E. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J. Clin. Endocrinol. Metab. 2006, 91:1309-1316. 10.1210/jc.2005-2099.
106. Palomba S., Falbo A., Zullo F., Orio F. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr. Rev. 2009, 30:1-50. 10.1210/er.2008-0030.
107. Panidis D., Rousso D., Koliakos G., Kourtis A., Katsikis I., Farmakiotis D., Votsi E., Diamanti-Kandarakis E. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil. Steril. 2006, 85:1778-1783. 10.1016/j.fertnstert.2005.11.044.
108. Pasquali R., Patton L., Gambineri A. Obesity and infertility. Curr. Opin. Endocrinol. Diabetes Obes. 2007, 14:482-487. 10.1097/MED.0b013e3282f1d6cb.
109. Pastor C.L., Griffin-Korf M.L., Aloi J.A., Evans W.S., Marshall J.C. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 1998, 83:582-590.
110. Pielecka J., Moenter S.M. Effect of steroid milieu on gonadotropin-releasing hormone-1 neuron firing pattern and luteinizing hormone levels in male mice. Biol. Reprod. 2006, 74:931-937. 10.1095/biolreprod.105.049619.
111. Pielecka J., Quaynor S.D., Moenter S.M. Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback. Endocrinology 2006, 147:1474-1479. 10.1210/en.2005-1029.
112. Randeva H.S., Tan B.K., Weickert M.O., Lois K., Nestler J.E., Sattar N., Lehnert H. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr. Rev. 2012, 33:812-841. 10.1210/er.2012-1003.
113. Reame N., Sauder S.E., Kelch R.P., Marshall J.C. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J. Clin. Endocrinol. Metab. 1984, 59:328-337.
114. Recabarren S.E., Padmanabhan V., Codner E., Lobos A., Durán C., Vidal M., Foster D.L., Sir-Petermann T. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E801-E806. 10.1152/ajpendo.00107.2005.
115. Robinson J.E., Forsdike R.A., Taylor J.A. In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology 1999, 140:5797-5805.
116. Robinson J.E., Birch R.A., Taylor J.A., Foster D.L., Padmanabhan V. In utero programming of sexually differentiated gonadotrophin releasing hormone (GnRH) secretion. Domest. Anim. Endocrinol. 2002, 23:43-52.
117. Rodríguez M., Arias P., Refojo D., Feleder C., Moguilevsky J. Arrest of pulsatile luteinizing hormone (LH) secretion during insulin-induced hypoglycemia (IIH): improvement by intrahypothalamic perfusion with glucose. Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc. 1999, 107:257-261.
118. Roland A.V., Moenter S.M. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology 2011, 152:618-628. 10.1210/en.2010-0823.
119. Roland A.V., Moenter S.M. Glucosensing by GnRH neurons: inhibition by androgens and involvement of AMP-activated protein kinase. Mol. Endocrinol. 2011, 25:847-858. 10.1210/me.2010-0508.
120. Roland A.V., Moenter S.M. Regulation of gonadotropin-releasing hormone neurons by glucose. Trends Endocrinol. Metab. (TEM) 2011, 22:443-449. 10.1016/j.tem.2011.07.001.
121. Roland A.V., Nunemaker C.S., Keller S.R., Moenter S.M. Prenatal androgen exposure programs metabolic dysfunction in female mice. J. Endocrinol. 2010, 207:213-223. 10.1677/JOE-10-0217.
122. San Millán J.L., Cortón M., Villuendas G., Sancho J., Peral B., Escobar-Morreale H.F. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J. Clin. Endocrinol. Metab. 2004, 89:2640-2646. 10.1210/jc.2003-031252.
123. Sarma H.N., Manikkam M., Herkimer C., Dell'Orco J., Welch K.B., Foster D.L., Padmanabhan V. Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 2005, 146:4281-4291. 10.1210/en.2005-0322.
124. Savabieasfahani M., Lee J.S., Herkimer C., Sharma T.P., Foster D.L., Padmanabhan V. Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period. Biol. Reprod. 2005, 72:221-229. 10.1095/biolreprod.104.031070.
125. Sharma T.P., Herkimer C., West C., Ye W., Birch R., Robinson J.E., Foster D.L., Padmanabhan V. Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol. Reprod. 2002, 66:924-933.
126. Simerly R.B., Swanson L.W., Handa R.J., Gorski R.A. Influence of perinatal androgen on the sexually dimorphic distribution of tyrosine hydroxylase-immunoreactive cells and fibers in the anteroventral periventricular nucleus of the rat. Neuroendocrinology 1985, 40:501-510.
127. Sir-Petermann T., Maliqueo M., Angel B., Lara H.E., Pérez-Bravo F., Recabarren S.E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod. Oxf. Engl. 2002, 17:2573-2579.
128. Sir-Petermann T., Hitchsfeld C., Maliqueo M., Codner E., Echiburú B., Gazitúa R., Recabarren S., Cassorla F. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum. Reprod. Oxf. Engl. 2005, 20:2122-2126. 10.1093/humrep/dei009.
129. Smith J.T. Sex steroid regulation of kisspeptin circuits. Adv. Exp. Med. Biol. 2013, 784:275-295. 10.1007/978-1-4614-6199-9_13.
130. Steckler T.L., Herkimer C., Dumesic D.A., Padmanabhan V. Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication for polycystic ovary syndrome. Endocrinology 2009, 150:1456-1465. 10.1210/en.2008-1256.
131. Steiner R.A., Clifton D.K., Spies H.G., Resko J.A. Sexual differentiation and feedback control of luteinizing hormone secretion in the rhesus monkey. Biol. Reprod. 1976, 15:206-212.
132. Strauss J.F., McAllister J.M., Urbanek M. Persistence pays off for PCOS gene prospectors. J. Clin. Endocrinol. Metab. 2012, 97:2286-2288. 10.1210/jc.2012-2109.
133. Sullivan S.D., Moenter S.M. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc. Natl. Acad. Sci. USA 2004, 101:7129-7134. 10.1073/pnas.0308058101.
134. Sullivan S.D., Moenter S.M. Gamma-aminobutyric acid neurons integrate and rapidly transmit permissive and inhibitory metabolic cues to gonadotropin-releasing hormone neurons. Endocrinology 2004, 145:1194-1202. 10.1210/en.2003-1374.
135. Sullivan S.D., Moenter S.M. GABAergic integration of progesterone and androgen feedback to gonadotropin-releasing hormone neurons. Biol. Reprod. 2005, 72:33-41. 10.1095/biolreprod.104.033126.
136. Sullivan S.D., Howard L.C., Clayton A.H., Moenter S.M. Serotonergic activation rescues reproductive function in fasted mice: does serotonin mediate the metabolic effects of leptin on reproduction?. Biol. Reprod. 2002, 66:1702-1706.
137. Sullivan S.D., DeFazio R.A., Moenter S.M. Metabolic regulation of fertility through presynaptic and postsynaptic signaling to gonadotropin-releasing hormone neurons. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23:8578-8585.
138. Sun J., Moenter S.M. Progesterone treatment inhibits and dihydrotestosterone (DHT) treatment potentiates voltage-gated calcium currents in gonadotropin-releasing hormone (GnRH) neurons. Endocrinology 2010, 151:5349-5358. 10.1210/en.2010-0385.
139. Sun J., Chu Z., Moenter S.M. Diurnal in vivo and rapid in vitro effects of estradiol on voltage-gated calcium channels in gonadotropin-releasing hormone neurons. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:3912-3923. 10.1523/JNEUROSCI.6256-09.2010.
140. Suter K.J., Song W.J., Sampson T.L., Wuarin J.P., Saunders J.T., Dudek F.E., Moenter S.M. Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology. Endocrinology 2000, 141:412-419.
141. Taylor A.E., McCourt B., Martin K.A., Anderson E.J., Adams J.M., Schoenfeld D., Hall J.E. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1997, 82:2248-2256.
142. Tortoriello D.V., McMinn J., Chua S.C. Dietary-induced obesity and hypothalamic infertility in female DBA/2J mice. Endocrinology 2004, 145:1238-1247. 10.1210/en.2003-1406.
143. Unsworth W.P., Taylor J.A., Robinson J.E. Prenatal programming of reproductive neuroendocrine function: the effect of prenatal androgens on the development of estrogen positive feedback and ovarian cycles in the ewe. Biol. Reprod. 2005, 72:619-627. 10.1095/biolreprod.104.035691.
144. Veiga-Lopez A., Ye W., Phillips D.J., Herkimer C., Knight P.G., Padmanabhan V. Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep. Biol. Reprod. 2008, 78:636-647. 10.1095/biolreprod.107.065904.
145. Veiga-Lopez A., Astapova O.I., Aizenberg E.F., Lee J.S., Padmanabhan V. Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol. Reprod. 2009, 80:718-725. 10.1095/biolreprod.108.074781.
146. Veldhuis J.D., Johnson M.L. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am. J. Physiol. 1986, 250:E486-E493.
147. Wade G.N., Schneider J.E., Li H.Y. Control of fertility by metabolic cues. Am. J. Physiol. 1996, 270:E1-E19.
148. Waldstreicher J., Santoro N.F., Hall J.E., Filicori M., Crowley W.F. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J. Clin. Endocrinol. Metab. 1988, 66:165-172.
149. Welt C.K., Styrkarsdottir U., Ehrmann D.A., Thorleifsson G., Arason G., Gudmundsson J.A., Ober C., Rosenfield R.L., Saxena R., Thorsteinsdottir U., Crowley W.F., Stefansson K. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J. Clin. Endocrinol. Metab. 2012, 97:E1342-E1347. 10.1210/jc.2011-3478.
150. Wildt L., Häusler A., Marshall G., Hutchison J.S., Plant T.M., Belchetz P.E., Knobil E. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 1981, 109:376-385.
151. Witchel S.F., Tena-Sempere M. The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications. Fertil. Steril. 2013, 100:12-22. 10.1016/j.fertnstert.2013.05.024.
152. Witham E.A., Meadows J.D., Shojaei S., Kauffman A.S., Mellon P.L. Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in mice. Endocrinology 2012, 153:4522-4532. 10.1210/en.2012-1283.
153. Witkin J.W., Xiao E., Popilskis S., Ferin M., Silverman A.J. FOS expression in the gonadotropin-releasing hormone (GnRH) neuron does not increase during the ovarian steroid-induced GnRH surge in the rhesus monkey. Endocrinology 1994, 135:956-961.
154. Wood R.I., Ebling F.J., I'Anson H., Bucholtz D.C., Yellon S.M., Foster D.L. Prenatal androgens time neuroendocrine sexual maturation. Endocrinology 1991, 128:2457-2468.
155. Wood R.I., Mehta V., Herbosa C.G., Foster D.L. Prenatal testosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in the developing sheep. Neuroendocrinology 1995, 62:238-247.
156. Wood R.I., Kim S.J., Foster D.L. Prenatal androgens defeminize activation of GnRH neurons in response to estradiol stimulation. J. Neuroendocrinol. 1996, 8:617-625.
157. Wu X.-Y., Li Z.-L., Wu C.-Y., Liu Y.-M., Lin H., Wang S.-H., Xiao W.-F. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats. Endocr. J. 2010, 57:201-209.
158. Wu S., Divall S., Wondisford F., Wolfe A. Reproductive tissues maintain insulin sensitivity in diet-induced obesity. Diabetes 2012, 61:114-123. 10.2337/db11-0956.
159. Wu S., Divall S., Nwaopara A., Radovick S., Wondisford F., Ko C., Wolfe A. Obesity induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes 2013, 10.2337/db13-1514.
160. Yan X., Dai X., Wang J., Zhao N., Cui Y., Liu J. Prenatal androgen excess programs metabolic derangements in pubertal female rats. J. Endocrinol. 2013, 217:119-129. 10.1530/JOE-12-0577.
161. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40:638-645. 10.1038/ng.120.
162. Zhang C., Bosch M.A., Levine J.E., Rønnekleiv O.K., Kelly M.J. Gonadotropin-releasing hormone neurons express K(ATP) channels that are regulated by estrogen and responsive to glucose and metabolic inhibition. J. Neurosci. Off. J. Soc. Neurosci. 2007, 27:10153-10164. 10.1523/JNEUROSCI.1657-07.2007.